Cardiac Clinical Trial Studies Use of Antibiotic In Preventing Heart Attack

HIGHLIGHTS: A clinical trial currently under way at Cedars-Sinai Medical Center could have profound ramifications for preventing recurring heart attacks by using a common, inexpensive antibiotic. AVAILABLE FOR INTERVIEWS: Bojan Cercek, M.D., Ph.D., Director, Coronary Care Unit, Cedars-Sinai Medical Center P.K.Shah, M.D., Chairman, Division of Cardiology, Cedars-Sinai Medical Center; Professor of Medicine, UCLA School of Medicine. LOS ANGELES (November 12, 1998) - A common, inexpensive antibiotic could reduce a second heart attack in patients who have already suffered an acute heart attack. In a clinical trial involving 1,400 patients, Cedars-Sinai Medical Center scientists, as well as collaborators at two facilities in Israel and three in Europe, are testing the effectiveness of the common antibiotic, Azithromycin, in preventing recurrent heart attacks.

"Of people who have just had a heart attack, 20 to 25 percent are likely to have another heart attack within the next six months," says Bojan Cercek, M.D., Ph.D., Lead Investigator and Director of the Coronary Care Unit at Cedars-Sinai.

"There is a growing body of scientific evidence implicating ongoing inflammation (accumulation of white blood cells) in plaque formation and plaque disruption that leads to blood clots and heart attacks, says P.K.Shah, M.D., Chairman of Cardiology at Cedars-Sinai.

According to Dr. Shah, "Cholesterol accumulation inside the plaque provides one of the stimuli for inflammation; the other may be bacterial/viral infection of the plaque. Therefore we designed the current AZACS study to determine the potential value of antibiotics for heart attack prevention."

"Chlamydia pneumonia, a common bacteria that causes respiratory infections, has been identified in 30 to 40 percent of plaques where it may stimulate the white blood cells to trigger a heart attack," says Dr. Cercek. "If this hypothesis is correct, treating the patient with the antibiotic Azithromycin

Contact: Sandra Van
Cedars-Sinai Medical Center

Page: 1 2

Related biology news :

1. Cardiac arrest may hinder ability to learn certain tasks
2. Cardiac stress tests may indicate if blockages will recur after angioplasty with stent implant
3. Cardiac surgery patients at higher risk
4. Sudden Cardiac Death May Run In Families
5. New Company Formed Through Licensing Of Cardiac-Hypertrophy Technology From Texas Institutions
6. Strategic Placement Of Automated External Defibrillators May Help Save Lives Of People Who Go Into Cardiac Arrest
7. Evaluation Of The Two Types Of Cardiac Pacemakers Indicates Only Modest Differences In Value
8. Family Ties To Sudden Cardiac Arrest; Study Finds Risk Goes Up 50 Percent
9. Study Reviews Medication Use In Elderly Cardiac Patients After Discharge
10. Researchers Find Association Between Alzheimers Gene And Mental Impairment After Cardiac Surgery
11. Creation of the UK Clinical Research Collaboration will boost clinical trials in UK

Post Your Comments:

(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: